Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fresubin Energy Fibre is a high-energy (1.5 kcal/mL), nutritionally complete enteral formula designed for the dietary management of patients with or at risk of disease-related malnutrition. Manufactured by Fresenius Kabi, it features a mixed fibre blend (including inulin, wheat dextrin, and cellulose) to support gastrointestinal health. The formulation provides a balanced profile of protein (from milk and soya), carbohydrates, and fats, supplemented with essential vitamins, minerals, and trace elements. It is specifically indicated for individuals with increased energy requirements, fluid restrictions, or conditions leading to loss of appetite and convalescence. The product is available as a ready-to-drink oral supplement in various flavors and as a tube feed, and it is both lactose-free and gluten-free.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fresubin Energy Fibre.